Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Elisa Anselmi"'
Autor:
Elena Orlandi, Mario Giuffrida, Serena Trubini, Enrico Luzietti, Massimo Ambroggi, Elisa Anselmi, Patrizio Capelli, Andrea Romboli
Publikováno v:
Diagnostics, Vol 14, Iss 10, p 1001 (2024)
Microsatellite Instability (MSI-H) occurs in approximately 15% of non-metastatic colon cancers, influencing patient outcomes positively compared to microsatellite stable (MSS) cancers. This systematic review focuses on the prognostic significance of
Externí odkaz:
https://doaj.org/article/2bc49396278849bfaa4c73abf4596ceb
Autor:
Margherita Ratti, Elena Orlandi, Jens Claus Hahne, Stefano Vecchia, Chiara Citterio, Elisa Anselmi, Ilaria Toscani, Michele Ghidini
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2650 (2023)
In carcinogenesis of the gastrointestinal (GI) tract, the deregulation of fibroblast growth factor receptor (FGFR) signaling plays a critical role. The aberrant activity of this pathway is described in approximately 10% of gastric cancers and its fre
Externí odkaz:
https://doaj.org/article/68a5bbd2820142d288ff5abf26233458
Autor:
Luigi Cavanna, Manuela Proietto, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Elisa Maria Stroppa, Maria Teresa Borsotti, Andrea Contini, Gabriella Di Girolamo, Vincenzo Matteo Quitadamo, Nicoletta Bacchetta, Monica Muroni, Maria Grazia Brescia, Marco Delledonne
Publikováno v:
Vaccines, Vol 10, Iss 2, p 164 (2022)
Patients with cancer have a high risk of intubation, intensive care unit admission, or death from the coronavirus disease (COVID-19); age and comorbidities are additional risk factors. Vaccination is effective against COVID-19; however, patients with
Externí odkaz:
https://doaj.org/article/04adf1392f3b43b38166b7a460a5a1b2
Autor:
Luigi Cavanna, Manuela Proietto, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Elisa Maria Stroppa, Maria Teresa Borsotti, Andrea Contini, Gabriella Di Girolamo, Vincenzo Matteo Quitadamo, Nicoletta Bacchetta, Monica Muroni, Maria Grazia Brescia, Marco Delledonne
Publikováno v:
Vaccines; Volume 10; Issue 2; Pages: 164
Patients with cancer have a high risk of intubation, intensive care unit admission, or death from the coronavirus disease (COVID-19); age and comorbidities are additional risk factors. Vaccination is effective against COVID-19; however, patients with
Autor:
Elena Zaffignani, Elisa Maria Stroppa, Mauro Codeluppi, Elisa Anselmi, Chiara Citterio, Luigi Cavanna, Ilaria Toscani
Publikováno v:
Future Oncology
Background: We describe cancer patients with coronavirus disease-2019 (COVID-19) infection treated at the Piacenza’s general hospital (north Italy). Materials & methods: 25 cancer patients infected by COVID-19 admitted at the Piacenza’s general h
Autor:
Camilla Di Nunzio, Luigi Cavanna, P. Mordenti, Pietro Seghini, Fabrizio Artioli, Claudia Biasini, Elisa Anselmi
Publikováno v:
Tumori Journal. 95:63-67
The disclosure of a diagnosis of cancer is complex, particularly in older patients for reasons related to the wishes of the family, fear of discouraging the patient, or the patient's inability to understand the information. So our insight into older
Autor:
Vittorio Callea, Elena Trabacchi, Luigi Cavanna, Daniele Vallisa, Antonio Lazzaro, Elisa Anselmi, Raffaella Bertè, Anna Lisa Arcari, Mario Lazzarino, Roberto Marasca, Patrizia Bernuzzi, Luca Arcaini, Carlo Filippo Moroni, Stefano Sacchi
Publikováno v:
Journal of Clinical Oncology. 23:468-473
PurposeHepatitis C virus (HCV) is endemic in some areas of Northwestern Europe and the United States. HCV has been shown to play a role in the development of both hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma (B-NHL). The biologic mechan
Autor:
Antonio Frassoldati, Antonella Ferro, Elisa Picardo, Sara Balduzzi, Michele Aieta, Federico Piacentini, Pierfranco Conte, Francesco Giotta, Giovanna Cavazzini, Giancarlo Bisagni, Elisa Anselmi, A. Turletti, Roberto D'Amico, Alba A. Brandes, Antonino Musolino, Vittorio Gebbia, Valentina Guarneri, Daniela Rubino, Cristiana Taverniti, Ornella Garrone
Publikováno v:
Journal of Clinical Oncology. 35:501-501
501 Background: 1-year trastuzumab with chemotherapy is the standard adjuvant treatment for HER2+ breast cancer patients (pts). The efficacy of less extended trastuzumab exposure is still under investigation. The Short-HER study is an independent, no
Autor:
Roberto, DI Cicilia, Patrizia, Mordenti, Elisa, Anselmi, Carlo, Paties, Egidio, Carella, Luigi, Cavanna
Publikováno v:
Anticancer research. 34(9)
Worldwide, gastric cancer is the fourth most commonly diagnosed type of cancer and the second most common cause of cancer-related death. Recently, it was demonstrated that 15-20% of advanced gastro-oesophageal carcinomas overexpress human epidermal r
Autor:
Annalisa, Arcari, Elisa, Anselmi, Patrizia, Bernuzzi, Raffaella, Berta, Antonio, Lazzaro, Carlo Filippo, Moroni, Elena, Trabacchi, Daniele, Vallisa, Andrea, Vercelli, Luigi, Cavanna
Publikováno v:
Haematologica. 90(1)